OPTASE- glycerin solution/ drops 
Scope Health Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Optase Dry Eye Intense Drops

active

Keep out of reach of children

Purpose

warnings

Uses

directions

inactives

Optase Intense Dry Eye Drops

OPTASE 
glycerin solution/ drops
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:72972-002
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN2 mg  in 1 mL
Inactive Ingredients
Ingredient NameStrength
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
HYDROCHLORIC ACID (UNII: QTT17582CB)  
WATER (UNII: 059QF0KO0R)  
TROMETHAMINE (UNII: 023C2WHX2V)  
SORBITOL (UNII: 506T60A25R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:72972-002-011 in 1 BOX02/14/2020
19.75 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalM01802/14/2020
Labeler - Scope Health Inc (116778693)
Registrant - Regulatory Matters Consulting (080711165)

Revised: 12/2022
Document Id: f1126333-5ff9-1291-e053-2a95a90a89c0
Set id: 9e96976b-2990-79e0-e053-2995a90a0f29
Version: 4
Effective Time: 20221230
 
Scope Health Inc